Open AccessLisocabtagene Maraleucel (Breyanzi)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.461
Subject(s) - reimbursement , lymphoma , follicular lymphoma , medicine , drug , chimeric antigen receptor , diffuse large b cell lymphoma , oncology , cancer research , cancer , immunotherapy , pharmacology , political science , health care , law